<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>EPiQ Life Science AB</title>
	<atom:link href="http://epiq.se/feed/langswitch_lang/en/" rel="self" type="application/rss+xml" />
	<link>http://epiq.se</link>
	<description></description>
	<lastBuildDate>Tue, 31 Jan 2012 16:12:05 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>January 2012. EPiQ moves</title>
		<link>http://epiq.se/2012/01/31/january-2012-epiq-moves/</link>
		<comments>http://epiq.se/2012/01/31/january-2012-epiq-moves/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 16:06:27 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Nyheter]]></category>

		<guid isPermaLink="false">http://epiq.se/?p=596</guid>
		<description><![CDATA[<p>EPiQ Life Science has relocated to new offices in Kista. The new 220 m2 office is located on Torshamnsgatan 30A, close to the Victoria Tower, the Scandic Victoria Tower and the Kistamässan (fair and conference center).</p> <p>CEO Per Sundström: -&#8221;With the new office we strengthen our ability to perform complex development in house. We also [...]]]></description>
			<content:encoded><![CDATA[<p>EPiQ Life Science has relocated to new offices in Kista.<br />
The new 220 m2 office is located on Torshamnsgatan 30A, close to the Victoria Tower, the Scandic Victoria Tower and the Kistamässan (fair and conference center).</p>
<p>CEO Per Sundström: -&#8221;With the new office we strengthen our ability to perform complex development in house. We also can grow and provide a stimulating workspace for our employees.&#8221;</p>
]]></content:encoded>
			<wfw:commentRss>http://epiq.se/2012/01/31/january-2012-epiq-moves/feed/langswitch_lang/en/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>January 2012. EPiQ on Facebook</title>
		<link>http://epiq.se/2012/01/31/epiq-facebook/</link>
		<comments>http://epiq.se/2012/01/31/epiq-facebook/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 16:03:56 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Nyheter]]></category>

		<guid isPermaLink="false">http://epiq.se/?p=593</guid>
		<description><![CDATA[<p>Make sure to follow EPiQ Life Science on Facebook.</p> <p>EPiQ Life Science AB</p> ]]></description>
			<content:encoded><![CDATA[<p>Make sure to follow EPiQ Life Science on Facebook.</p>
<p><a href="http://sv-se.facebook.com/EPiQLifeScience" target="_blank">EPiQ Life Science AB</a></p>
]]></content:encoded>
			<wfw:commentRss>http://epiq.se/2012/01/31/epiq-facebook/feed/langswitch_lang/en/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>September 2011. EPiQ at Medtech Investment Day September 8</title>
		<link>http://epiq.se/2011/09/02/september-2011-epiq-pa-medtech-investment-day-8-sep-2011/</link>
		<comments>http://epiq.se/2011/09/02/september-2011-epiq-pa-medtech-investment-day-8-sep-2011/#comments</comments>
		<pubDate>Fri, 02 Sep 2011 09:26:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Nyheter]]></category>

		<guid isPermaLink="false">http://epiq.se/?p=558</guid>
		<description><![CDATA[<p>EPiQ Life Science has been selecetd to perform a presentation at this years Medtech Investment Day at the Grand Hotel in Stockholm on September 8. The 25 nordic companies which has qualified for Medtech Investment Day has been put through a thorough selection process. One criteria is that they have an innovative product in the [...]]]></description>
			<content:encoded><![CDATA[<p>EPiQ Life Science has been selecetd to perform a presentation at this years Medtech Investment Day at the <a href="http://www.grandhotel.se/" target="_blank">Grand Hotel</a> in Stockholm on September 8.<br />
The 25 nordic companies which has qualified for Medtech Investment Day has been put through a thorough selection process. One criteria is that they have an innovative product in the medical field developed in house.</p>
<p>See external link:<a href="http://www.medtechinvestmentday.com/" target="_blank"><br />
Medtech Investment Day Scandinavia</a></p>
]]></content:encoded>
			<wfw:commentRss>http://epiq.se/2011/09/02/september-2011-epiq-pa-medtech-investment-day-8-sep-2011/feed/langswitch_lang/en/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>June 2011. EPiQ at EUROPACE 2011 June 26-29</title>
		<link>http://epiq.se/2011/06/26/juni-2011-epiq-pa-europace-2011-26-29-juni/</link>
		<comments>http://epiq.se/2011/06/26/juni-2011-epiq-pa-europace-2011-26-29-juni/#comments</comments>
		<pubDate>Sun, 26 Jun 2011 19:44:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Nyheter]]></category>

		<guid isPermaLink="false">http://epiq.se/?p=545</guid>
		<description><![CDATA[<p>EPiQ Life Science is exhibiting at EHRA EUROPACE 2011 in Madrid from June 26 &#8211; 29. Please visit our booth at D12 in the exhibition area. On display is our system AFRtracker. AFRtracker is used for ECG-based analysis of atrial fibrillation (AF) and calculates parameters emanating from the electrical activity in the left and right [...]]]></description>
			<content:encoded><![CDATA[<p>EPiQ Life Science is exhibiting at <a href="http://www.escardio.org/congresses/ehra-europace-2011/Pages/welcome.aspx" target="_blank">EHRA EUROPACE 2011</a> in Madrid from June 26 &#8211; 29.<br />
Please visit our booth at D12 in the exhibition area.<br />
On display is our system AFRtracker.<br />
AFRtracker is used for ECG-based analysis of atrial fibrillation (AF) and calculates parameters emanating from the electrical activity in the left and right atria, useful for deciding optimal treatment options for patients with AF &#8211; cardioversion, pharmaceutics, or ablation.</p>
]]></content:encoded>
			<wfw:commentRss>http://epiq.se/2011/06/26/juni-2011-epiq-pa-europace-2011-26-29-juni/feed/langswitch_lang/en/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>May 2011. EPiQ Life Science AB awarded €357 000 through Vinnova Forska&amp;Väx</title>
		<link>http://epiq.se/2011/05/11/maj-2011-epiq-life-science-ab-tilldelas-32-miljoner-sek-genom-vinnovas-forskavax/</link>
		<comments>http://epiq.se/2011/05/11/maj-2011-epiq-life-science-ab-tilldelas-32-miljoner-sek-genom-vinnovas-forskavax/#comments</comments>
		<pubDate>Wed, 11 May 2011 12:30:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Nyheter]]></category>

		<guid isPermaLink="false">http://epiq.se/?p=505</guid>
		<description><![CDATA[<p>EPiQ Life Science AB has been awarded 3,2 million Swedish Kronor, approximately €357 000, through the Vinnova program Forska&#38;Väx for continued development of AFRtracker, a product that assists in the decision making for patients diagnosed with atrial fibrillation. The technology in AFRtracker has been developed in co-operation with Cardiolund Research AB and has been through [...]]]></description>
			<content:encoded><![CDATA[<p><strong>EPiQ Life Science AB</strong> has been awarded 3,2 million Swedish Kronor, approximately €357 000, through the Vinnova program Forska&amp;Väx for continued development of <strong>AFRtracker</strong>, a product that assists in the decision making for patients diagnosed with atrial fibrillation.<br />
The technology in <strong>AFRtracker</strong> has been developed in co-operation with <strong>Cardiolund Research AB</strong> and has been through clinical studies in five countries during 2010 with good results.</p>
]]></content:encoded>
			<wfw:commentRss>http://epiq.se/2011/05/11/maj-2011-epiq-life-science-ab-tilldelas-32-miljoner-sek-genom-vinnovas-forskavax/feed/langswitch_lang/en/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>August 2010. Article in the Swedish journal Läkartidningen about FAF analysis</title>
		<link>http://epiq.se/2010/08/28/artikel-om-faf-analys-i-lakartidningen/</link>
		<comments>http://epiq.se/2010/08/28/artikel-om-faf-analys-i-lakartidningen/#comments</comments>
		<pubDate>Sat, 28 Aug 2010 14:00:54 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Nyheter]]></category>

		<guid isPermaLink="false">http://epiq.se/?p=493</guid>
		<description><![CDATA[<p>Sorry, but this page is not available in English</p> [...]]]></description>
			<content:encoded><![CDATA[<p>Sorry, but this page is not available in English</p>
]]></content:encoded>
			<wfw:commentRss>http://epiq.se/2010/08/28/artikel-om-faf-analys-i-lakartidningen/feed/langswitch_lang/en/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>August 2010. EPiQ at ESC August 28 – 31</title>
		<link>http://epiq.se/2010/08/28/augusti-2010-epiq-pa-esc-28-318/</link>
		<comments>http://epiq.se/2010/08/28/augusti-2010-epiq-pa-esc-28-318/#comments</comments>
		<pubDate>Sat, 28 Aug 2010 13:53:48 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Nyheter]]></category>

		<guid isPermaLink="false">http://epiq.se/?p=485</guid>
		<description><![CDATA[<p>Welcome to visit our booth at the European Society of Cardiology, ESC, in Älvsjö, Stockholm from August 28 to 31 2010. We are displaying in Hall C, C20:68. The congress is held at Stockholmsmässan.</p> [...]]]></description>
			<content:encoded><![CDATA[<p>Welcome to visit our booth at the<a href="http://www.escardio.org/congresses/esc-2010/Pages/welcome.aspx" target="_blank"> European Society of Cardiology</a>, ESC, in Älvsjö, Stockholm from August 28 to 31 2010.<br />
We are displaying in <strong>Hall C</strong>,<strong> C20:68</strong>.<br />
The congress is held at <a href="http://www.stofair.se/common/category.aspx?id=129" target="_blank">Stockholmsmässan</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://epiq.se/2010/08/28/augusti-2010-epiq-pa-esc-28-318/feed/langswitch_lang/en/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>June 2010. Launch of AFRtracker and AFRtracker.com</title>
		<link>http://epiq.se/2010/06/03/afrtracker/</link>
		<comments>http://epiq.se/2010/06/03/afrtracker/#comments</comments>
		<pubDate>Thu, 03 Jun 2010 08:32:48 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Nyheter]]></category>

		<guid isPermaLink="false">http://epiq.se/?p=454</guid>
		<description><![CDATA[<p>AFRtracker.com is an online service for state-of-the-art analysis of ECG signals from patients with atrial fibrillation (AF). The main purpose of the service is to provide clinicians and researchers as well as other systems with expert analysis of AF signals. AFRtracker.com calculates the average Atrial Fibrillatory Rate (AFR) in lead V1 of signals uploaded to [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://afrtracker.com">AFRtracker.com</a> is an online service for state-of-the-art analysis of ECG signals from patients with atrial fibrillation (AF). The main purpose of the service is to provide clinicians and researchers as well as other systems with expert analysis of AF signals. <a href="http://afrtracker.com">AFRtracker.com</a> calculates the average Atrial Fibrillatory Rate (AFR) in lead V1 of signals uploaded to our server via the web interface on this website. The analysis results are shortly thereafter available for download as a pdf report. The report also presents other signal discriptors than AFR, including AF amplitude, AF frequency variability, and a measure of AF organization.</p>
<p>AFR has been used in a large number of clinical studies (30+) investigating atrial signal properties in relation to prediction of DC conversion, drug therapy and ablation therapy outcome and recurrence, for prediction of spontaneous termination in paroxysmal cases of AF, for monitoring of antiarrhythmic drug actions, and for evaluation of spontaneous and intervention-induced autonomic changes.</p>
<p>Now you can include AFR in your own studies and products using your own data and our analysis server. Please go to our <a href="http://epiq.se/afrtracker">product page</a> for detailed information on how you or your customers can subscribe to this service.</p>
]]></content:encoded>
			<wfw:commentRss>http://epiq.se/2010/06/03/afrtracker/feed/langswitch_lang/en/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>December 2009. Graduation from the STING incubator</title>
		<link>http://epiq.se/2010/01/31/december-2009-graduation-from-the-sting-incubator/</link>
		<comments>http://epiq.se/2010/01/31/december-2009-graduation-from-the-sting-incubator/#comments</comments>
		<pubDate>Sun, 31 Jan 2010 14:33:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Nyheter]]></category>

		<guid isPermaLink="false">http://epiq.se/?p=333</guid>
		<description><![CDATA[<p class="wp-caption-text">EPiQ @ STING Takeoff December 2009</p> <p> Claudijo Borovic, co-founder Wussap and Per Sundström, CEO at EPiQ Life Science AB, with the certificates during the cermoni at STING December 8 2009.</p> <p>Photo: STING</p> <p>EPiQ graduates from the business incubator at Stockholm Innovation &#38; Growth. At a cermony in Kista the CEO of STING Pär [...]]]></description>
			<content:encoded><![CDATA[<div id="attachment_332" class="wp-caption aligncenter" style="width: 510px"><a href="http://epiq.se/wordpress/wp-content/uploads/2010/01/takeoff_2009-12-08.jpg"><img class="size-full wp-image-332" title="EPiQ at STING Dec 2009" src="http://epiq.se/wordpress/wp-content/uploads/2010/01/takeoff_2009-12-08.jpg" alt="" width="500" height="363" /></a><p class="wp-caption-text">EPiQ @ STING Takeoff December 2009</p></div>
<p> <em>Claudijo Borovic, co-founder Wussap and <strong>Per Sundström</strong>, CEO at <strong>EPiQ Life Science AB</strong>, with the certificates during the cermoni at STING December 8 2009.</em></p>
<p><em>Photo: STING</em></p>
<p>EPiQ graduates from the business incubator at Stockholm Innovation &amp; Growth.<br />
At a cermony in Kista the CEO of STING Pär Hedberg hands out words of wisdom and the diploma.</p>
<p>Read the full press release here: <a href="http://www.stockholminnovation.com/EN/429/sting-companies-epiq-and-wussap-ready-for-global-take-off" target="_blank">STING companies EPiQ and Wussap ready for global take off</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://epiq.se/2010/01/31/december-2009-graduation-from-the-sting-incubator/feed/langswitch_lang/en/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>June 2009. Clinical study</title>
		<link>http://epiq.se/2009/08/19/juni-2009-klinisk-studie/</link>
		<comments>http://epiq.se/2009/08/19/juni-2009-klinisk-studie/#comments</comments>
		<pubDate>Wed, 19 Aug 2009 20:55:40 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Nyheter]]></category>

		<guid isPermaLink="false">http://10.9.0.2/wordpress/?p=273</guid>
		<description><![CDATA[<p>Sorry, but this page is not available in English</p> ]]></description>
			<content:encoded><![CDATA[<p>Sorry, but this page is not available in English</p>
]]></content:encoded>
			<wfw:commentRss>http://epiq.se/2009/08/19/juni-2009-klinisk-studie/feed/langswitch_lang/en/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

